---
category: news
title: "BioXcel Therapeutics Reports Financial Results for the Fourth Quarter and Full Year 2023"
excerpt: "Provides update on two late-stage clinical programs for BXCL501 for potential treatment of agitationRecently completed meetings with U.S. Food"
publishedDateTime: 2024-03-12T11:51:00Z
originalUrl: "https://markets.businessinsider.com/news/stocks/bioxcel-therapeutics-reports-financial-results-for-the-fourth-quarter-and-full-year-2023-1033154353"
webUrl: "https://markets.businessinsider.com/news/stocks/bioxcel-therapeutics-reports-financial-results-for-the-fourth-quarter-and-full-year-2023-1033154353"
type: article
quality: 25
heat: 25
published: false

provider:
  name: Business Insider
  domain: businessinsider.com
  images:
    - url: "https://everyday-cc.github.io/ai/assets/images/organizations/businessinsider.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - AI in Healthcare
  - AI

secured: "EZjGORNbMvfBQr75YhkpyNrloPiPReKungwqVTZgdyLY/Syy9bMmkKrvSkCTH13xhJMqv9DGXPHbU8FIusOh6Oc+A5RsofvV8cxBUcebqcQWccdhL8uD52rqh+Vc1Bx7MZS/dKyTYSo+QTOmJM4l/n6cWGUwV2EZJdQ8wOPRvDS+YN1OsW/3fOucKIzK6UEs31nZImob1THgqa2h5C0c01mGRtFsUGG9VJFY5jJZ0Bz9bFCNxR14YuWy4csOAxdycZaFuRdfdtYoMBXRfg3ZQ8luJwmLYAUqQAB5Us6semo3duI1CKvfKjIX+wSwqZ5K7iLZLD6iCUP8+lgVRvFWxa2X0qOTTWBcJJhQr+i7l2M=;88/ONoB44ifzDDC9pMWDNw=="
---

